EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

S. Gaucher; S. M. Lwin; M. Titeux; A. Abdul-Wahab; N. Pironon; A. Izmiryan; S. Miskinyte; C. Ganier; S. Duchatelet; J. E. Mellerio; E. Bourrat; J. A. McGrath; A. Hovnanian

doi:10.1111/bjd.18559

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

S. Gaucher, S. M. Lwin, M. Titeux, A. Abdul-Wahab, N. Pironon, A. Izmiryan, S. Miskinyte, C. Ganier, S. Duchatelet, J. E. Mellerio, E. Bourrat, J. A. McGrath, A. Hovnanian

Department of Dermatology

Research output: Contribution to journal › Letter › peer-review

22 Citations (Scopus)

Original language	English
Pages (from-to)	794-797
Number of pages	4
Journal	British Journal of Dermatology
Volume	182
Issue number	3
DOIs	https://doi.org/10.1111/bjd.18559
Publication status	Published - 2020 Mar 1

All Science Journal Classification (ASJC) codes

Dermatology

Access to Document

10.1111/bjd.18559

Cite this

Gaucher, S., Lwin, S. M., Titeux, M., Abdul-Wahab, A., Pironon, N., Izmiryan, A., Miskinyte, S., Ganier, C., Duchatelet, S., Mellerio, J. E., Bourrat, E., McGrath, J. A., & Hovnanian, A. (2020). EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa. British Journal of Dermatology, 182(3), 794-797. https://doi.org/10.1111/bjd.18559

@article{4ecf52822f14427bb4a8b55f2cddcb48,

title = "EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa",

author = "S. Gaucher and Lwin, {S. M.} and M. Titeux and A. Abdul-Wahab and N. Pironon and A. Izmiryan and S. Miskinyte and C. Ganier and S. Duchatelet and Mellerio, {J. E.} and E. Bourrat and McGrath, {J. A.} and A. Hovnanian",

year = "2020",

month = mar,

day = "1",

doi = "10.1111/bjd.18559",

language = "English",

volume = "182",

pages = "794--797",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "3",

}

Gaucher, S, Lwin, SM, Titeux, M, Abdul-Wahab, A, Pironon, N, Izmiryan, A, Miskinyte, S, Ganier, C, Duchatelet, S, Mellerio, JE, Bourrat, E, McGrath, JA & Hovnanian, A 2020, 'EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa', British Journal of Dermatology, vol. 182, no. 3, pp. 794-797. https://doi.org/10.1111/bjd.18559

TY - JOUR

T1 - EBGene trial

T2 - patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

AU - Gaucher, S.

AU - Lwin, S. M.

AU - Titeux, M.

AU - Abdul-Wahab, A.

AU - Pironon, N.

AU - Izmiryan, A.

AU - Miskinyte, S.

AU - Ganier, C.

AU - Duchatelet, S.

AU - Mellerio, J. E.

AU - Bourrat, E.

AU - McGrath, J. A.

AU - Hovnanian, A.

PY - 2020/3/1

Y1 - 2020/3/1

UR - http://www.scopus.com/inward/record.url?scp=85075159048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075159048&partnerID=8YFLogxK

U2 - 10.1111/bjd.18559

DO - 10.1111/bjd.18559

M3 - Letter

C2 - 31557321

AN - SCOPUS:85075159048

SN - 0007-0963

VL - 182

SP - 794

EP - 797

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

EBGene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this